DNA Today is a multi-award winning podcast and radio show exploring how genetics impacts our health.

Host/Producer Kira Dineen interviews leaders in genetics including genetic counselors, researchers, physicians and patient advocates.

New episodes every Friday.

DNA Today is broadcast Fridays at 10:30am EST on WHUS 91.7 FM in Connecticut.

#420 NSGC 2026: Ambry's Whole Genome Sequencing and BillionToOne's Unity Confirm

#420 NSGC 2026: Ambry's Whole Genome Sequencing and BillionToOne's Unity Confirm

In this episode, we're coming to you from Baltimore for the National Society of Genetic Counselors (NSGC) 2026 Annual Conference! From new approaches to whole genome sequencing to the ability to analyze intact fetal cells through a pregnant person’s blood sample, we're exploring two exciting advances in genetic testing that could change how patients receive answers.

Host Kira Dineen sits down with experts from Ambry Genetics and BillionToOne to discuss new technologies unveiled at the conference, their clinical applications, and how they could improve diagnostic accuracy and accessibility.

We also celebrate Genetic Counselor Appreciation Day, highlight memorable moments from NSGC 2026, and share a special thank-you following Kira's recognition with the NSGC Leader in Community Engagement Award!

Featured Guests

Thomas "TJ" Slavin Jr., MD, is the Chief Medical Officer of Ambry Genetics and a medical geneticist. He joins us to discuss Ambry Genetics' newly launched whole genome sequencing offerings, GenomeNext and GenomeReveal, and how integrating RNA analysis, pangenome references, and proactive reanalysis could help end the diagnostic odyssey for more families.

Jennifer "Jen" Hoskovec, MS, CGC, is Vice President of Medical Affairs at BillionToOne and a past president of NSGC (2014). She returns to DNA Today to introduce Unity Confirm, a new prenatal testing option that isolates and sequences intact circulating placental cells from a pregnant person’s blood to provide additional information following high-risk NIPT results.

In This Episode We Discuss

Ambry Genetics: Whole Genome Sequencing, RNA Analysis, and the Pangenome

  • How Tempus' acquisition of Ambry Genetics brings together tumor sequencing and germline testing capabilities.

  • Why Ambry chose 2026 to launch GenomeNext and GenomeReveal and how whole genome sequencing is changing rare disease diagnostics.

  • How RNA analysis can help clarify variants of uncertain significance (VUS), particularly variants that may affect RNA splicing.

  • Why incorporating a human pangenome reference can improve variant detection across diverse ancestral populations and help address disparities in genetic testing.

  • How Ambry's Patient for Life program proactively reanalyzes genetic data and contacts providers when new evidence leads to clinically meaningful changes.

  • Why identifying dual genetic diagnoses is increasingly important and how ongoing reanalysis can reveal additional explanations for a patient's symptoms.

BillionToOne: Unity Confirm and Cell-Based Prenatal Testing

  • How Unity Confirm differs from traditional cell-free DNA screening by isolating intact circulating extravillous trophoblasts from a pregnant person’s blood.

  • How sequencing individual placental cells can provide additional information following a high-risk NIPT result.

  • Why Unity Confirm is positioned as an additional testing option rather than a replacement for diagnostic procedures such as chorionic villus sampling (CVS) or amniocentesis.

  • How this technology could help patients who decline invasive testing or face geographic, financial, or gestational-age barriers to accessing diagnostic procedures.

  • The limitations of analyzing a small number of cells, particularly when considering placental mosaicism and conditions such as Turner syndrome.

  • How staining techniques and genetic comparisons help distinguish placental trophoblasts from maternal white blood cells.

  • How genetic counselors can integrate another source of prenatal information into patient-centered conversations about screening, diagnosis, and reproductive decision-making.

Resources & Links

NSGC Annual Conference

National Society of Genetic Counselors (NSGC) – Learn more about NSGC, its annual conference, and resources for genetic counseling professionals.

Ambry Genetics and Whole Genome Sequencing

  • Ambry Genetics – Explore Ambry's clinical genetic testing services and resources.

  • GenomeNext and GenomeReveal Launch Announcement – Learn how Ambry integrates whole genome sequencing, RNA analysis, pangenome references, and ongoing reanalysis to improve rare disease diagnosis.

  • GenomeNext and GenomeReveal – Explore the technologies and clinical capabilities behind Ambry's new whole genome sequencing offerings.

  • Patient for Life White Paper – Learn how Ambry's proactive reanalysis program identifies new diagnostic findings as genetic knowledge evolves.

  • Tempus AI – Learn about Ambry's parent company and its work in precision medicine.

Fact Check: Kira misspoke when she said Ambry has been analyzing RNA as part of clinical testing for 15 years, she was thinking of Ambry offering the first clinical exome as that was launched in 2011. 

BillionToOne and Prenatal Testing

Relevant DNA Today Episodes

We've been recapping the NSGC Annual Conference every year since 2019! Catch up on our previous conference coverage to see how the field of genetic counseling has evolved over the years: #111 NSGC 2019 Recap, #135 NSGC 2020 Recap, #157 NSGC 2021 Recap, #212 NSGC 2022 Recap, #259 NSGC 2023 Recap, #307 NSGC 2024 Recap, and #366 NSGC 2025 Recap.

- #182 Eric Green on the Complete Human Genome Project - Dr. Eric Green discusses the completion of the human genome sequence and the Telomere-to-Telomere Consortium, foundational advances that paved the way for today's whole genome sequencing technologies.

- #370 Genetics Wrapped: 2025 Top Advances in Genomic Medicine - Dr. Eric Green returns to review major genomic breakthroughs, including the Human Pangenome Project and its importance for improving representation and equity in genetic testing.

- #303 RNA Analysis with Ambry Genetics - Dr. Rachid Karam explains how Ambry integrates RNA analysis to clarify uncertain variants and improve diagnostic yield, a technology now incorporated into GenomeReveal.

- #297 Exome Reanalysis with Ambry Genetics - Kelly Hagman and Dr. Elizabeth Chao discuss Ambry's Patient for Life program and how proactive genetic reanalysis can uncover diagnoses as scientific knowledge evolves.

- #385 Inside ACMG 2026: How AI and New Tools Enhance Genome Sequencing and Equity - Explores how RNA sequencing, long-read sequencing, artificial intelligence, and other emerging tools are improving whole genome interpretation and addressing diagnostic disparities.

- #224 Single-Gene Noninvasive Prenatal Testing (NIPT) with BillionToOne - Jennifer Hoskovec and Dr. Oguzhan Atay explain BillionToOne's approach to single-gene NIPT, providing background on the company's prenatal testing innovations before the introduction of Unity Confirm.

- #225 Fetal Antigen Noninvasive Prenatal Testing (NIPT) with BillionToOne - Jennifer Hoskovec returns to discuss noninvasive fetal antigen testing, highlighting another advance in prenatal testing from BillionToOne before its latest cell-based technology.


Connect with DNA Today:

You never have to wait long for a new episode of DNA Today, we release episodes every Friday! In the meantime, explore our library of over 400 episodes on Apple Podcasts, Spotify, DNAToday.com, or wherever you listen to podcasts. Just search “DNA Today.”

Prefer to watch? The video version of this episode is available on our YouTube channel and DNAToday.com. Select episodes are filmed in person, including some at the iconic NBCUniversal studios.

Discover more podcasts exploring genetics, genomics, medicine, and science from our network, Gene Pool Media: The Science Podcast Network.

DNA Today is hosted and executive produced by Kira Dineen, MS, LCGC, CG(ASCP)CM. Our associate producer for this episode is Jess Rizzo, CGC. Liv Davidson is our Social Media Lead. 

Follow us at @DNATodayPodcast on all platforms including Instagram, X, BluSky, Threads, LinkedIn, Facebook, YouTube and our website, DNAToday.com. 

Questions, partnership inquiries, and guest pitches can be sent to info@DNAToday.com.

#419 Optical Genome Mapping and Long-Read Sequencing: Unlocking Rare Diagnoses

#419 Optical Genome Mapping and Long-Read Sequencing: Unlocking Rare Diagnoses